Idylla GeneFusion Panel
European CE-IVD qPCR panel for ALK, ROS1, RET and MET exon 14 molecular testing in non-small cell lung cancer.
- Developer
- Biocartis
- Intended use
- Other
- Cancer scope
- Non-small cell lung cancer
- Specimen
- FFPE tumor tissue
- Molecular modality
- RNA
- Current version
- Current European diagnostic Idylla GeneFusion Panel A0120/6; ALK/ROS1/RET fusions plus MET exon 14 skipping
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.